H. Ikeda

发表

Correlation of circulating betatrophin concentrations with insulin secretion capacity, evaluated by glucagon stimulation tests

A. Hamasaki, K. Fujimoto, S. Tokumoto, 2015, Diabetic medicine : a journal of the British Diabetic Association.

Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus

M. Namba, H. Ikeda, T. Katsuno, 2016, Diabetes Therapy.

Drugs share antidiabetic and antiatherosclerotic actions through "the common soil".

Y. Hamamoto, S. Honjo, H. Ikeda, 2006, Medical hypotheses.

Pitavastatin reduces elevated IL-18 levels in Japanese subjects with hypercholesterolemia: sub-analysis of Kansai investigation of statin for hyperlipidemic intervention in metabolism and endocrinology (KISHIMEN).

K. Hirata, K. Tsuda, Yoshio Nakamura, 2011, Journal of atherosclerosis and thrombosis.

Effects of pitavastatin on lipid profiles and high-sensitivity CRP in Japanese subjects with hypercholesterolemia: Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology (KISHIMEN) investigatars.

K. Hirata, K. Tsuda, Y. Seino, 2008, Journal of atherosclerosis and thrombosis.

A case of diabetic ketoacidosis associated with Guillain-Barré syndrome.

Y. Kawasaki, Y. Hamamoto, S. Honjo, 2011, Internal medicine.

Urinary IgG4 and Smad1 Are Specific Biomarkers for Renal Structural and Functional Changes in Early Stages of Diabetic Nephropathy

Taichi Murakami, S. Kishi, K. Nagai, 2018, Diabetes.

Olmesartan reduced microalbuminuria in Japanese subjects with type 2 diabetes.

Y. Hamamoto, S. Honjo, H. Ikeda, 2009, Diabetes research and clinical practice.

Primary aldosteronism associated with subclinical Cushing syndrome

H. Sasano, K. Fujimoto, Y. Kawasaki, 2012, Journal of Endocrinological Investigation.

Relationship Between CarotidIntima-Media Thickness and Silent Cerebral Infarction in Japanese Subjects With Type 2 Diabetes

Y. Hamamoto, S. Honjo, H. Ikeda, 2009, Diabetes Care.

Comparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study: amlodipine vs. ARB in atherosclerosis study).

Yoshio Nakamura, Y. Hamamoto, S. Honjo, 2009, Diabetes research and clinical practice.

Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus.

M. Namba, J. Miyagawa, H. Ikeda, 2013, Endocrine journal.

Japanese cases of acute onset diabetic ketosis without acidosis in the absence of glutamic acid decarboxylase autoantibody

Y. Kawasaki, Y. Hamamoto, S. Honjo, 2010, Endocrine.

Improvement of insulin resistance following transsphenoidal surgery in patients with acromegaly: Correlation with serum IGF-I levels

K. Fujimoto, Y. Hamamoto, S. Honjo, 2013, Journal of Endocrinological Investigation.

Relationship between Telmisartan Dose and Glycaemic Control in Japanese Patients with Type 2 Diabetes Mellitus and Hypertension

K. Fujimoto, Y. Kawasaki, Y. Hamamoto, 2012, Clinical Drug Investigation.

Relationship between telmisartan dose and glycaemic control in Japanese patients with type 2 diabetes mellitus and hypertension: a retrospective study.

K. Fujimoto, Y. Kawasaki, Y. Hamamoto, 2012, Clinical drug investigation.

A case of lymphocytic panhypophysitis (LPH) during pregnancy

T. Sano, T. Aoki, Y. Hamamoto, 2007, Endocrine.

The role of the TSC-22 (-396) A/G variant in the development of diabetic nephropathy.

Yuichiro Yamada, Y. Seino, A. Hamasaki, 2003, Diabetes research and clinical practice.

Hypovitaminosis D is frequent in Japanese subjects with type 2 diabetes.

Yoshio Nakamura, N. Tsugawa, T. Okano, 2007, Diabetes research and clinical practice.

Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study

K. Fujimoto, S. Tokumoto, Y. Hamamoto, 2017, Clinical Drug Investigation.

Efficacy and Safety of Miglitol: Switching Study from Voglibose in Japanese Patients with Type 2 Diabetes

Y. Kawasaki, Y. Hamamoto, S. Honjo, 2009 .

Lymphocytic Panhypophysitis: its Clinical Features in Japanese Cases

A. Shimatsu, Yoshio Nakamura, Y. Kawasaki, 2011, Japanese clinical medicine.

Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy.

Y. Hamamoto, S. Honjo, H. Ikeda, 2009, Diabetes research and clinical practice.

The limited usefulness of the treadmill test or a risk-guided approach in screening for asymptomatic coronary heart disease in Japanese patients with type 2 diabetes.

R. Nohara, Y. Hamamoto, S. Honjo, 2012, Internal medicine.

Long‐term (52‐week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT‐2 study

C. Mathieu, E. Araki, N. Iqbal, 2021, Diabetes, obesity & metabolism.

Less variation of R-R interval of electrocardiogram in nonobese type 2 diabetes with nocturnal intermittent hypoxia.

Y. Kawasaki, Y. Hamamoto, S. Honjo, 2013, Endocrine journal.

Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study

H. Koyama, H. Ikeda, T. Katsuno, 2020, Journal of diabetes investigation.

Impact of COVID‐19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study

M. Matsuhisa, K. Miyo, H. Yokoyama, 2023, Journal of diabetes investigation.

Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes.

Yukiko Kawasaki, Jun Fujikawa, K. Fujimoto, 2013, Diabetes research and clinical practice.